This cohort study evaluated racial and ethnic disparities in retention in buprenorphine and methadone treatment among pregnant females with opioid use disorder (OUD) in the US.
The abstract provides insufficient detail to assess specific limitations such as sample size, follow-up duration, confounders adjusted for, or outcome definitions.
Clinicians treating pregnant patients with OUD should be aware that racial and ethnic disparities in treatment retention may exist, warranting targeted support strategies for at-risk groups.
Explore related topics
